Hybridoma cells were produced by fusing P3X63Ag8.653 mouse myeloma cells with spleen cells from BALB/c mice immunized with Japanese encephalitis (JE) virus, Nakayama-RFVL strain. The resulting 26 clones produced hemagglutination inhibition antibodies against the homologous strain. The hemagglutination inhibition reactivity of each clone was tested against six flaviviruses: JE, Murray Valley encephalitis (MVE), Egypt 101 strain of West Nile (WN), St. Louis encephalitis (SLE), Russian spring summer encephalitis, and dengue type 1. The 26 monoclonal antibodies fell into four groups: 14 JE species-specific antibodies, 6 antibodies reactive to JE and MVE viruses, 3 antibodies to three or four viruses in the JE-MVE-WN-SLE subgroup, and 3 antibodies to all six flaviviruses. Furthermore, antigenic comparison of 27 strains of JE virus was carried out by using five JE species-specific monoclonal antibodies. Of these, 24 strains were isolated in various parts of Japan, and 3 strains came from Southeast Asia. In reactivity, the 27 strains were classified into at least four antigenic groups. The results showed that the Nakayama-Yakken strain is a mutant strain which lacks the Nakayama strain-specific antigen and that the recently isolated strains are immunologically different from Nakayama and JaGAr 01 strains. One clone (NARMA 13) produced a JE species-specific antibody which showed almost the same titer against 26 JE virus strains, whereas one clone (NARMA 5) produced a Nakayama strain-specific antibody which reacted only to the Nakayama-RFVL and Nakayama-Yoken strains.
Japanese encephalitis (JE) virus belongs to the genus Flavivirus according to its physicochemical properties. The virus has also been classified as a group B arbovirus by its epidemiological and serological properties.
Since Casals and Brown (4) in 1954 showed cross-reactivity of arboviruses by using the hemagglutination inhibition (HI) test, many arboviruses have been serologically classified into several groups by use of the HI test, the complement-fixation test, or the neutralization test. Flaviviruses (group B arboviruses) revealed marked cross-reactivity to each other against conventional hyperimmune animal antisera. Particularly, JE, Murray Valley encephalitis (MVE), West Nile (WN), and St. Louis encephalitis (SLE) viruses have exhibited close antigenic relationships under various serological procedures (2, 18) . However, the HI test has been the best method for the demonstration of antigenic relationships among the members of flaviviruses. Moreover, Clarke (5) has applied the antibody absorption technique of the HI test to the analysis of relationships among certain flaviviruses.
On the other hand, Hale and Lee (8) , in 1954 , observed that the properties of six strains of JE virus isolated in Malaya showed dissimilarity to those of the Nakayama strain. Since then, comparative studies of the antigenic structures of JE virus have been performed by many investigators (1, 10, 14, 16, 19) .
It is considered that the monoclonal antibody initially developed by Kohler and Milstein (15) is a powerful tool in the antigenic analysis of flaviviruses. Monoclonal antibodies against flaviviruses have been prepared for analysis of dengue virus serotypes by Dittmar et al. (7) , for study of the * Corresponding author.
phenomenon of antibody-dependent enhancement of replication with the use of WN virus by Peiris et al. (17) , and for antigenic analysis of tick-borne encephalitis virus by Heinz et al. (11) .
In this report, we describe the characterization of 26 monoclonal antibodies against the Nakayama-RFVL strain of JE virus and the results of the antigenic analysis of 27 JE virus strains by using 5 JE species-specific monoclonal antibodies. to 2 x 107/ml in HT medium, and 100 RI of the suspension was placed into each well of 96-well plates. The suspensions of hybridoma cells at a concentration of six cells per ml were prepared in HT medium by the limiting dilution method, and 100 ,ul of the suspension was added to each well of the plates.
MATERIALS
Colonies appeared in 10 to 14 days after seeding. The supernatants from single-colony wells were screened and the antibody-producing hybridoma cells were recloned as previously described. These clones were subsequently expanded into mass culture and frozen to assure retension.
For production of ascitic fluids, BALB/c mice were injected intraperitoneally with 0.5 ml of Pristane (Aldrich) 7 Determination of antibody class and subclass. Monoclonality of hybridoma antibodies was evaluated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and microOuchterlony method. The hybridoma cells were cultured in RPMI 1640 medium, supplemented with 1% gamma globulinfree fetal calf serum (GIBCO). After being concentrated by the 50% saturated ammonium sulfate precipitation method and undergoing affinity chromatography with DEAE AffiGel Blue (Bio-Rad), these supernatants were analyzed by 5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and the micro-Ouchterlony method against rabbit antisera reacting with mouse specific immunoglobulins: immunoglobulin G (IgG), IgGl, IgG2a, IgG2b, IgG3, IgM, IgA, K, and A chains (Miles).
Analysis of chromosomes in hybridomas. The karyotype was analyzed at the metaphase stage of mitotic cells by adding colchicine (GIBCO) to give a final concentration of 0.07 ,ug/ml to the culture medium on day 2 or 3. At 2 h later, the cells were harvested, fixed in methanolacetic acid (3:1) and stained by the Giesma method.
HI tests. HI tests were performed by the method of Clarke and Casals (6) . The antigens were prepared by the sucroseacetone extraction method. A dilution of each antigen was made in cold bovine albumin-borate-saline to give an estimated 8 of JE virus. Fourteen monoclonal antibodies, NARMA 1 to 14, were tested against the four JE virus strains, Nakayama-RFVL, Nakayama-Yoken, JaGAr 01, and Kamiyama. They consisted of the following antibodies (Table 4) .
(i) NARMA 5 and 6 showed almost the same titer against the Nakayama-RFVL and Nakayama-Yoken strains, but did not react to the other strains. These antibodies showed Nakayama strain-specificity.
(ii) NARMA 1, 2, and 8 showed 1:1 to 1:4 against the Kamiyama strain as compared with that of the Nakayama-RFVL strain, and lower or negative against the JaGAr 01 strain.
(iii) NARMA 4 had a titer of 1:64 against the JaGAr 01 and Kamiyama strains as compared with that of the Nakayama-RFVL strain.
(iv) NARMA 10 to 14 showed almost the same titer against the four strains and the antibodies produced by the remaining three clones showed the titers of intermediate type. Table 5 . According to the pattern of reactivity against the antibodies, the 27 strains are classified into the following groups:
(i) The Nakayama-RFVL and Nakayama-Yoken strains showed high titers against five antibodies. On the other hand, the Nakayama-Yakken strain showed the same titer against NARMA 4, lower against NARMA 1, 8, and 13 as compared with the Nakayama-RFVL strain, and negative against NARMA 5. Although Nakayama-Yakken strain is derived from the same origin as Nakayama-RFVL and Nakayama-Yoken strains, an antigenic difference was observed between the Nakayama-Yakken strain and the other two Nakayama strains. Thus, the Nakayama-RFVL and Nakayama-Yoken strains are referred to as group I-1, and the Nakayama-Yakken strain is referred to as group I-2.
(ii) Four strains, Kalinina, G-1 late, JaGAr 01, and JaGAr 02, showed almost the same titer against NARMA 80679 , Chiang Mai, and 691004, showed almost the same titer against NARMA 1 and 13 as the Nakayama-RFVL strain, and reacted to NARMA 4 and 8 to various degrees, but not to NARMA 5. However, the titer of the 691004 strain against NARMA 4 and 8 was nearly the same as that of the Nakayama-RFVL strain and higher than that of the other strains in this group. In addition, this strain had a higher titer against NARMA 4 than that against NARMA 8, whereas the remaining 18 strains were higher against NARMA 8 than against NARMA 4. Therefore, the 691004 strain may be immunologically different from the other 18 strains. These 18 strains are referred to as group III-1, and the 691004 strain is referred to as group III-2.
(iv) The Muar strain, referred to as group IV, showed almost the same titer against NARMA 13 and a lower titer against NARMA 1 as compared with the Nakayama-RFVL strain, but did not react to NARMA 4, 5, and 8.
NARMA 13 is regarded as a typical JE species-specific antibody, because this antibody demonstrated almost the same titer against all JE virus strains used in this study except for the Nakayama-Yakken strain. In contrast, NARMA 5 is a Nakayama strain-specific antibody, because this reacted only to the Nakayama-RFVL and NakayamaYoken strains but not to other strains. The NakayamaYakken strain is immunologically distinguished from the other two Nakayama strains, especially in its lack of reaction to NARMA 5. It is suggested that the Muar strain is the most antigenically different from the Nakayama-RFVL strain. Table 6 indicates the relationship between the antigenic differences and the year of isolation of 27 JE virus strains. In Japan, 24 strains isolated from different areas between 1935 and 1979 fell into at least three antigenic groups, I, II, and III-1. The Nakayama strains ( Fourteen of these antibodies, NARMA 1 to 14, reacted only to JE virus and showed varied reactive characterization in the HI test against four JE virus strains: Nakayama-RFVL, Nakayama-Yoken, JaGAr 01, and Kamiyama. NARMA 13 and 14 were typical species-specific antibodies. On the other hand, NARMA 5 and 6 were strict Nakayama strain-specific antibodies. The other antibodies showed intermediate reactivities. The Nakayama strain, isolated in 1935, was the first strain of JE virus. Since then, the strain has been maintained in several different laboratories by prolonged mouse brain passages. The Nakayama-RVFL strain was kept in the Rockefeller Foundation Virus Laboratories and is now in the Yale Arbovirus Research Unit, New Haven, Conn., and is a reference strain of JE virus. The Nakayama-Yoken strain has been maintained in the National Institute of Health, Japan, and has been used as a vaccine strain for humans. The optimal pH of hemagglutination of the Nakayama-RFVL antigen was 6.5, whereas that of the Nakayama-Yoken antigen was 6.3. In spite of their different histories and different optimal pH values of hemagglutination these two Nakayama antigens showed almost the same titer against NARMA 1 to 14. These findings indicate that Nakayama-RFVL strain and Nakayama-Yoken strain are antigenically identical. Three strains of JE virus, Nakayama, JaGAr 01 and Kamiyama, were used to compare the reactivity of the 14 antibodies. NARMA 5 and 6 reacted only 
